Loading...
•
Jul 31
Nordson Q3 2025 Earnings Report
Nordson delivered strong Q3 performance with double-digit sales and earnings growth, driven by segment execution and operational leverage.
Key Takeaways
Nordson Corporation reported a robust third quarter with 12% year-over-year sales growth to $742 million. Adjusted EPS rose 13% to $2.73, driven by strong performance in Advanced Technology Solutions and Medical and Fluid Solutions. Free cash flow conversion reached 180%, reflecting operational strength and efficient capital use.
Sales reached $742 million, up 12% YoY
Net income grew to $126 million, with diluted EPS of $2.22
Adjusted EPS rose 13% to $2.73
Free cash flow conversion hit 180% of net income
Nordson
Nordson
Nordson Revenue by Segment
Nordson Revenue by Geographic Location
Revenue by Segment
Industrial Precision Revenue
CapyFin.comMedical & Fluid Revenue
CapyFin.comAdvanced Tech Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEurope Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
Management reaffirmed full-year guidance, with full-year adjusted EPS now tracking slightly above the midpoint and revenue slightly below.
Positive Outlook
- Adjusted EPS trending above guidance midpoint
- Strong segment execution, particularly in Advanced Tech
- Continued benefits from Atrion acquisition
- High free cash flow conversion supports capital allocation
- NBS Next strategy supporting resilience and growth
Challenges Ahead
- Backlog declined 5% sequentially
- Headwinds in polymer processing segment
- Currency volatility impact on Europe sales
- Pending medical divestiture impacting visibility
- High interest expense from acquisition-related debt
Revenue & Expenses
Visualization of income flow from segment revenue to net income